Denali Therapeutics Current Deferred Revenue (Quarterly) Trends

Denali Therapeutics, Inc. (DNLI)

16.35 -0.23 (-1.39%) USD | NASDAQ | Dec 30, 12:13

View Current Deferred Revenue (Quarterly) for DNLI.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Masimo Corp.	Upgrade
Novavax, Inc.	Upgrade
Protalix Biotherapeutics, Inc.	Upgrade
iRhythm Technologies, Inc.	Upgrade
Twist Bioscience Corp.	Upgrade